ENB Therapeutics' Seed VC Round

ENB Therapeutics raised a round of funding on September 21, 2018. Investors include BioAdvance.

ENB Therapeutics is developing therapies to break the drug resistance that occurs in over 50% of cancer patients.…

Articles about ENB Therapeutics' Seed VC Round: